Triazine derivatives and their application as antitelomerase agents
US6887873B2 · kind B2 · utility
2Cited by
2References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2002 |
| Grant date | May 3, 2005 |
| Priority date | — |
| Expiry date | Mar 25, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.